Mcgeady Stephen J MD

Dr. Stephen J. McGeady is a sole proprietorship medical expert practice located in Cherry Hill, New Jersey, specializing in providing medical expert services to the federal government. Registered in SAM.gov since 2008, the practice operates as a for-profit organization primarily focused on supporting the National Vaccine Injury Compensation Program (VICP) administered by the Health Resources and Services Administration (HRSA) within the Department of Health and Human Services. As a small business entity, Dr. McGeady offers specialized medical expertise in reviewing and analyzing complex medical cases related to vaccine injury claims.

The federal contract awards demonstrate that Dr. McGeady provides targeted medical expert services exclusively for the Vaccine Injury Compensation Program. These services involve detailed case reviews where he analyzes medical records, evaluates evidence, and assesses potential causal relationships between vaccine administration and claimed injuries or deaths. The contract awards, ranging from $1,125 to $11,250, are typically firm fixed-price Blanket Purchase Agreement (BPA) call orders. Many of these contracts have been designated as total small business set-asides, reflecting Dr. McGeady's status as a small business. The funding agency for all contracts is consistently the Health Resources and Services Administration (HRSA) Headquarters, and the contracts span multiple years, with completion dates ranging from 2021 to 2026.

Dr. McGeady holds a single-award Blanket Purchase Agreement (BPA) with HRSA, valued at $249,999 and valid through July 2026. This IDV serves as the primary contract vehicle for procuring his medical expert services for the Vaccine Injury Compensation Program. The IDV allows HRSA to efficiently access Dr. McGeady's specialized medical expertise for evaluating VICP petitions, with individual task orders being issued as needed. The BPA supports HRSA's mission of providing a no-fault alternative to civil litigation for individuals who may have been injured by specific vaccines. Through this IDV, Dr. McGeady can be called upon to provide critical medical insights that help HRSA uniformly and equitably assess petitioner eligibility under the VICP guidelines.